• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAGE适配体可阻断实验性糖尿病肾病的发生与发展。

RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.

作者信息

Matsui Takanori, Higashimoto Yuichiro, Nishino Yuri, Nakamura Nobutaka, Fukami Kei, Yamagishi Sho-Ichi

机构信息

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.

Department of Chemistry, Kurume University School of Medicine, Kurume, Japan.

出版信息

Diabetes. 2017 Jun;66(6):1683-1695. doi: 10.2337/db16-1281. Epub 2017 Apr 6.

DOI:10.2337/db16-1281
PMID:28385802
Abstract

The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) plays a central role in diabetic nephropathy. We screened DNA aptamers directed against RAGE (RAGE-aptamers) in vitro and examined the effects on the development and progression of diabetic nephropathy in streptozotocin-induced diabetic rats. RAGE-aptamer bound to RAGE with a of 5.68 nmol/L and resultantly blocked the binding of AGEs to RAGE. When diabetic rats received continuous intraperitoneal injection of RAGE-aptamer from week 7 to 11 of diabetes, the increases in renal NADPH oxidase activity, oxidative stress generation, AGE, RAGE, inflammatory and fibrotic gene and protein levels, macrophage and extracellular matrix accumulation, and albuminuria were significantly suppressed, which were associated with improvement of podocyte damage. Two-week infusion of RAGE-aptamer just after the induction of diabetes also inhibited the AGE-RAGE-oxidative stress system and MCP-1 levels in the kidneys of 8-week-old diabetic rats and simultaneously ameliorated podocyte injury and albuminuria. Moreover, RAGE-aptamer significantly suppressed the AGE-induced oxidative stress generation and inflammatory and fibrotic reactions in human cultured mesangial cells. The findings suggest that continuous infusion of RAGE-aptamer could attenuate the development and progression of experimental diabetic nephropathy by blocking the AGE-RAGE axis.

摘要

晚期糖基化终末产物(AGEs)与其受体(RAGE)的相互作用在糖尿病肾病中起核心作用。我们在体外筛选了针对RAGE的DNA适配体(RAGE-适配体),并研究了其对链脲佐菌素诱导的糖尿病大鼠糖尿病肾病发生发展的影响。RAGE-适配体与RAGE结合,解离常数为5.68 nmol/L,从而阻断了AGEs与RAGE的结合。当糖尿病大鼠在糖尿病第7周至11周期间连续腹腔注射RAGE-适配体时,肾NADPH氧化酶活性增加、氧化应激产生、AGE、RAGE、炎症和纤维化基因及蛋白水平、巨噬细胞和细胞外基质积聚以及蛋白尿均受到显著抑制,这与足细胞损伤的改善相关。在糖尿病诱导后立即进行为期两周的RAGE-适配体输注,也抑制了8周龄糖尿病大鼠肾脏中的AGE-RAGE-氧化应激系统和MCP-1水平,同时改善了足细胞损伤和蛋白尿。此外,RAGE-适配体显著抑制了人培养系膜细胞中AGE诱导的氧化应激产生以及炎症和纤维化反应。这些发现表明,持续输注RAGE-适配体可通过阻断AGE-RAGE轴减轻实验性糖尿病肾病的发生和发展。

相似文献

1
RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.RAGE适配体可阻断实验性糖尿病肾病的发生与发展。
Diabetes. 2017 Jun;66(6):1683-1695. doi: 10.2337/db16-1281. Epub 2017 Apr 6.
2
DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.针对晚期糖基化终产物受体的 DNA 适体可抑制糖尿病小鼠肾小管损伤并改善胰岛素抵抗。
Diab Vasc Dis Res. 2021 Jan-Feb;18(1):1479164121990533. doi: 10.1177/1479164121990533.
3
Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.丹酚酸A通过抑制晚期糖基化终产物-晚期糖基化终产物受体(AGE-RAGE)信号通路改善肾小球内皮功能障碍,从而预防糖尿病肾病。
Cell Physiol Biochem. 2017;44(6):2378-2394. doi: 10.1159/000486154. Epub 2017 Dec 18.
4
DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy.针对晚期糖基化终产物(AGEs)的 DNA 适体可阻止实验性糖尿病肾病的进展。
Diabetes. 2013 Sep;62(9):3241-50. doi: 10.2337/db12-1608. Epub 2013 Apr 29.
5
Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.川西小石积提取物可抑制糖尿病条件下系膜细胞中晚期糖基化终产物受体的结合及转化生长因子-β1的表达。
Phytomedicine. 2016 Apr 15;23(4):388-97. doi: 10.1016/j.phymed.2016.02.005. Epub 2016 Feb 21.
6
The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.牡丹皮对糖基化终产物诱导的大鼠肾小球系膜细胞功能障碍及高糖高脂饮食联合链脲佐菌素诱导的糖尿病肾病大鼠的抗炎作用。
J Ethnopharmacol. 2014;151(1):591-600. doi: 10.1016/j.jep.2013.11.015. Epub 2013 Nov 21.
7
Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.生长停滞特异性蛋白 2 样蛋白 1 在足细胞中通过晚期糖基化终产物而上调表达。
Nephrol Dial Transplant. 2017 Apr 1;32(4):641-653. doi: 10.1093/ndt/gfw313.
8
DNA aptamer raised against advanced glycation end products (AGEs) improves glycemic control and decreases adipocyte size in fructose-fed rats by suppressing AGE-RAGE axis.针对晚期糖基化终产物(AGEs)产生的DNA适配体通过抑制AGE-RAGE轴改善了果糖喂养大鼠的血糖控制并减小了脂肪细胞大小。
Horm Metab Res. 2015 Apr;47(4):253-8. doi: 10.1055/s-0034-1385904. Epub 2014 Aug 8.
9
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.胰高血糖素样肽-1 受体激动剂通过阻断晚期糖基化终产物诱导的蛋白精氨酸甲基转移酶-1 表达抑制链脲佐菌素诱导的糖尿病大鼠肾脏中不对称二甲基精氨酸的产生。
Am J Pathol. 2013 Jan;182(1):132-41. doi: 10.1016/j.ajpath.2012.09.016. Epub 2012 Nov 14.
10
AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.AGE-RAGE 轴阻断在糖尿病肾病中的应用:现状与未来方向。
Eur J Pharmacol. 2018 Aug 15;833:158-164. doi: 10.1016/j.ejphar.2018.06.001. Epub 2018 Jun 5.

引用本文的文献

1
Mechanisms of diabetic kidney disease and established and emerging treatments.糖尿病肾病的发病机制以及已有的和新出现的治疗方法。
Nat Rev Endocrinol. 2025 Sep 11. doi: 10.1038/s41574-025-01171-3.
2
Sulforaphane inhibits cardiac fibrosis induced by advanced glycation end product-receptor axis through its anti-oxidative property.萝卜硫素通过其抗氧化特性抑制晚期糖基化终产物受体轴诱导的心脏纤维化。
Acta Diabetol. 2025 Aug 11. doi: 10.1007/s00592-025-02545-9.
3
Apixaban Inhibits Progression of Experimental Diabetic Nephropathy by Blocking Advanced Glycation End Product-Receptor Axis.
阿哌沙班通过阻断晚期糖基化终末产物-受体轴抑制实验性糖尿病肾病的进展。
Int J Mol Sci. 2025 Mar 26;26(7):3007. doi: 10.3390/ijms26073007.
4
Screening and Identification of Novel DNA Aptamer for Targeted Delivery to Injured Podocytes in Glomerular Diseases.用于靶向递送至肾小球疾病中损伤足细胞的新型DNA适配体的筛选与鉴定
Adv Sci (Weinh). 2025 May;12(20):e2412356. doi: 10.1002/advs.202412356. Epub 2025 Apr 3.
5
The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease.晚期糖基化终末产物在肾脏疾病发生发展中的潜在作用
Nutrients. 2025 Feb 21;17(5):758. doi: 10.3390/nu17050758.
6
RNA-Based Therapies in Kidney Diseases.基于RNA的肾脏疾病治疗方法
J Inflamm Res. 2025 Mar 4;18:3143-3160. doi: 10.2147/JIR.S505252. eCollection 2025.
7
Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product-receptor axis.恩格列净通过阻断晚期糖基化终产物受体轴改善肥胖2型糖尿病小鼠的肾脏和代谢紊乱。
Mol Med. 2025 Mar 6;31(1):88. doi: 10.1186/s10020-025-01138-0.
8
Involvement of Mineralocorticoid Receptor Activation by High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Development of Acute Kidney Injury.高迁移率族蛋白盒1和晚期糖基化终产物受体激活盐皮质激素受体在急性肾损伤发生发展中的作用
Kidney360. 2025 Feb 1;6(2):208-218. doi: 10.34067/KID.0000000665. Epub 2024 Dec 5.
9
Gene therapy and kidney diseases.基因治疗与肾脏疾病。
Mol Ther Methods Clin Dev. 2024 Sep 6;32(4):101333. doi: 10.1016/j.omtm.2024.101333. eCollection 2024 Dec 12.
10
Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation.葡萄糖依赖性胰岛素多肽通过激活 AMPK 部分抑制 AGE 诱导的 NADPH 氧化酶衍生的氧化应激产生和巨噬细胞中的泡沫细胞形成。
Int J Mol Sci. 2024 Sep 8;25(17):9724. doi: 10.3390/ijms25179724.